Singapore · Delayed Price · Currency is SGD UG Healthcare Corporation Statistics
Total Valuation
SGXC:8K7 has a market cap or net worth of SGD 45.54 million. The enterprise value is 56.66 million.
| Market Cap | 45.54M |
| Enterprise Value | 56.66M |
Important Dates
The next estimated earnings date is Tuesday, November 10, 2026.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SGXC:8K7 has 623.83 million shares outstanding.
| Current Share Class | 623.83M |
| Shares Outstanding | 623.83M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.74% |
| Owned by Institutions (%) | 2.99% |
| Float | 216.76M |
Valuation Ratios
The trailing PE ratio is 21.70.
| PE Ratio | 21.70 |
| Forward PE | n/a |
| PS Ratio | 0.30 |
| PB Ratio | 0.27 |
| P/TBV Ratio | 0.31 |
| P/FCF Ratio | 3.17 |
| P/OCF Ratio | 2.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.95, with an EV/FCF ratio of 3.95.
| EV / Earnings | 26.99 |
| EV / Sales | 0.38 |
| EV / EBITDA | 4.95 |
| EV / EBIT | 10.14 |
| EV / FCF | 3.95 |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.24.
| Current Ratio | 2.82 |
| Quick Ratio | 1.60 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 3.55 |
| Debt / FCF | 2.82 |
| Interest Coverage | 2.19 |
Financial Efficiency
Return on equity (ROE) is 1.61% and return on invested capital (ROIC) is 2.01%.
| Return on Equity (ROE) | 1.61% |
| Return on Assets (ROA) | 1.46% |
| Return on Invested Capital (ROIC) | 2.01% |
| Return on Capital Employed (ROCE) | 2.90% |
| Weighted Average Cost of Capital (WACC) | 6.62% |
| Revenue Per Employee | 180,196 |
| Profits Per Employee | 2,508 |
| Employee Count | 837 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, SGXC:8K7 has paid 1.35 million in taxes.
| Income Tax | 1.35M |
| Effective Tax Rate | 33.80% |
Stock Price Statistics
The stock price has decreased by -27.00% in the last 52 weeks. The beta is 0.83, so SGXC:8K7's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -27.00% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 47.34 |
| Average Volume (20 Days) | 99,080 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SGXC:8K7 had revenue of SGD 150.82 million and earned 2.10 million in profits. Earnings per share was 0.00.
| Revenue | 150.82M |
| Gross Profit | 42.87M |
| Operating Income | 5.56M |
| Pretax Income | 4.00M |
| Net Income | 2.10M |
| EBITDA | 11.42M |
| EBIT | 5.56M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 27.41 million in cash and 40.52 million in debt, with a net cash position of -13.11 million or -0.02 per share.
| Cash & Cash Equivalents | 27.41M |
| Total Debt | 40.52M |
| Net Cash | -13.11M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | 169.77M |
| Book Value Per Share | 0.28 |
| Working Capital | 88.39M |
Cash Flow
In the last 12 months, operating cash flow was 16.96 million and capital expenditures -2.62 million, giving a free cash flow of 14.35 million.
| Operating Cash Flow | 16.96M |
| Capital Expenditures | -2.62M |
| Depreciation & Amortization | 5.86M |
| Net Borrowing | -11.20M |
| Free Cash Flow | 14.35M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 28.42%, with operating and profit margins of 3.68% and 1.39%.
| Gross Margin | 28.42% |
| Operating Margin | 3.68% |
| Pretax Margin | 2.65% |
| Profit Margin | 1.39% |
| EBITDA Margin | 7.57% |
| EBIT Margin | 3.68% |
| FCF Margin | 9.51% |
Dividends & Yields
SGXC:8K7 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.61% |
| FCF Yield | 31.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 30, 2020. It was a forward split with a ratio of 3.
| Last Split Date | Sep 30, 2020 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
SGXC:8K7 has an Altman Z-Score of 2.66 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.66 |
| Piotroski F-Score | 8 |